BOLODEOKU, J.; GBAA, T.; MORRIS, K.; WHITEHEAD, S. Medicine Optimisation Using PCSK9 Monoclonal Antibodies (alirocumab and evolocumab) Concerning the European Atherosclerosis Society (EAS) of < 1.8 mmol/l LDL Cholesterol Target in a Secondary Care Lipid Clinic. British Journal of Healthcare and Medical Research, [S. l.], v. 10, n. 6, p. 91–102, 2023. DOI: 10.14738/bjhmr.106.15955. Disponível em: https://journals.scholarpublishing.org/index.php/JBEMi/article/view/15955. Acesso em: 21 nov. 2024.